Citigroup Inc Alkermes Plc. Transaction History

Citigroup Inc

$196 Billion
Q2 2025

A detailed history of Citigroup Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Citigroup Inc holds 187,846 shares of ALKS stock, worth $5.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

187,846

Previous 362,385 48.16%

Holding current value

$5.14 Million

Previous $12 Million 55.09%

% of portfolio

0.0%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$26.59 - $32.65 $4.64 Million - $5.7 Million	-174,539 Reduced 48.16%	187,846 $5.37 Million
Q1 2025 May 12, 2025	BUY	$28.08 - $36.0 $862,533 - $1.11 Million	30,717 Added 9.26%	362,385 $12 Million
Q4 2024 Feb 12, 2025	BUY	$25.7 - $31.46 $2.75 Million - $3.36 Million	106,810 Added 47.5%	331,668 $9.54 Million
Q3 2024 Nov 12, 2024	BUY	$23.01 - $28.55 $1.51 Million - $1.87 Million	65,536 Added 41.13%	224,858 $6.29 Million
Q2 2024 Aug 12, 2024	SELL	$23.21 - $27.24 $5.71 Million - $6.7 Million	-246,083 Reduced 60.7%	159,322 $3.84 Million
Q1 2024 May 10, 2024	BUY	$26.4 - $32.56 $3.98 Million - $4.91 Million	150,729 Added 59.18%	405,405 $11 Million
Q4 2023 Feb 09, 2024	BUY	$23.37 - $28.68 $1.45 Million - $1.78 Million	62,020 Added 32.19%	254,676 $7.06 Million
Q3 2023 Nov 09, 2023	BUY	$27.17 - $31.97 $540,981 - $636,554	19,911 Added 11.53%	192,656 $5.4 Million
Q2 2023 Aug 10, 2023	SELL	$28.34 - $33.63 $1.5 Million - $1.78 Million	-52,781 Reduced 23.4%	172,745 $5.41 Million
Q1 2023 May 11, 2023	BUY	$25.31 - $29.02 $1.57 Million - $1.8 Million	62,056 Added 37.96%	225,526 $6.36 Million
Q4 2022 Feb 09, 2023	SELL	$21.94 - $26.24 $2.98 Million - $3.57 Million	-135,895 Reduced 45.39%	163,470 $4.27 Million
Q3 2022 Nov 10, 2022	SELL	$22.0 - $31.87 $231,264 - $335,017	-10,512 Reduced 3.39%	299,365 $6.68 Million
Q2 2022 Aug 10, 2022	BUY	$26.4 - $30.54 $5.09 Million - $5.89 Million	192,915 Added 164.94%	309,877 $9.23 Million
Q1 2022 May 12, 2022	SELL	$23.07 - $27.99 $2.96 Million - $3.59 Million	-128,093 Reduced 52.27%	116,962 $3.08 Million
Q4 2021 Feb 10, 2022	BUY	$21.47 - $32.08 $1.34 Million - $2.01 Million	62,634 Added 34.33%	245,055 $5.7 Million
Q3 2021 Nov 10, 2021	BUY	$23.37 - $32.13 $4.26 Million - $5.86 Million	182,421 New	182,421 $5.63 Million

Others Institutions Holding ALKS

# of Institutions

394

Shares Held

176M

Call Options Held

558K

Put Options Held

427K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.49B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account